Confirmed speakers

 

Tony Mire-Sluis, Chair – IABS Human Therapeutics Committee

Maneesha Altekar, AstraZeneca

Lisa Bernstein, Roche-Genentech

Bruno Boulanger, Arlenda

Rick Burdick, Elion Labs

Oana Danila, Roche

Kristi Griffiths, Eli Lilly and Company

Roger Hart, Amgen

Mark Johnson, AbbVie

Ruojia Li, Bristol-Myers Squibb

Areti Manola, Janssen

Laura Pack, Seattle Genetics

Jose Ramirez, Amgen

Andrew Rugaiganisa, Pfizer

Tim Schofield, GlaxoSmithKline

Meiyu Shen, FDA

Perceval Sondag, Arlenda

Yi Tsong, FDA

Mike Walsh, Health Canada

Dan Weese, Amgen

Florian Wolschin, Sandoz / Novartis

Lixin Xu, FDA

Harry Yang, MedImmune